New tool aims to help heart failure patients get the right meds

NCT ID NCT07670845

Not yet recruiting Disease control Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a web-based tool called SHARE-HF that helps heart failure patients and their doctors make medication decisions together. The tool shows personalized prognosis and medication options. Researchers will compare clinics using the tool to those with usual care, involving 1350 adults with heart failure with reduced ejection fraction in British Columbia, Canada.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SHARE-HF decision aid (web-based tool)
What this could lead to: If it works, this tool could help more heart failure patients receive the right medications, potentially improving their health and quality of life.
What could go wrong: This is a pragmatic implementation study, not a test of a new drug. The tool may not significantly change medication use, and results may vary across clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)

More trials for these conditions

Other studies related to the condition(s) this trial covers.